What is the REVEAL study, and why is it so important to polycythemia vera (PV) patients? On location at the 2015 American Society of Hematology (ASH) annual meeting, MPN expert Dr. Brady Stein from Robert H. Lurie Comprehensive Cancer Center discusses the demographics and benefits of the study. Dr. Stein is particularly hopeful with the new developments and sophisticated prognosis being applied to PV. You can learn more about the REVEAL study at revealpvstudy.com.
Get email alerts | http://www.patientpower.info/alerts
Subscribe on YouTube | http://www.youtube.com/patientpower
Like on Facebook | http://www.fb.com/patientpower.info
Follow on Twitter | http://www.twitter.com/patientpower
Follow on Google+ | http://www.google.com/+patientpowerinfo